Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis.

Saurabh GuptaKevin J UmArjun PandeyWilliam F McIntyreMarina IvanovaYasamin AllahverdiParisa AgahiFeny PandyaAna LopezAmrit SachdevaRichard P WhitlockEmilie P Belley-Cote

Published in: Cardiovascular drugs and therapy (2020)

DOACs peri-cardioversion in patients with AF appears safe from both a bleeding and thromboembolic risk perspective. Available evidence supports the use of DOACs as standard of care peri-cardioversion in patients with AF.

Keyphrases

atrial fibrillation
direct oral anticoagulants
patients undergoing
oral anticoagulants
catheter ablation
left atrial
left atrial appendage
heart failure
healthcare
palliative care
percutaneous coronary intervention
quality improvement
coronary artery disease